Thermo Fisher Scientific Inc. (NEO:TMO)
Canada
· Delayed Price · Currency is CAD 15.57
-0.37 (-2.32%)
Apr 24, 2025, 12:55 PM EDT
Thermo Fisher Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 42,898 | 42,879 | 42,857 | 44,915 | 39,211 | 32,218 | Upgrade
|
| Revenue Growth (YoY) | 0.95% | 0.05% | -4.58% | 14.55% | 21.70% | 26.14% | Upgrade
|
| Cost of Revenue | 25,153 | 25,130 | 25,662 | 25,944 | 19,573 | 16,214 | Upgrade
|
| Gross Profit | 17,745 | 17,749 | 17,195 | 18,971 | 19,638 | 16,004 | Upgrade
|
| Selling, General & Admin | 8,590 | 8,595 | 8,381 | 8,940 | 7,857 | 6,940 | Upgrade
|
| Research & Development | 1,401 | 1,390 | 1,337 | 1,471 | 1,406 | 1,181 | Upgrade
|
| Other Operating Expenses | 30 | 30 | 1 | - | 3 | 16 | Upgrade
|
| Operating Expenses | 9,899 | 10,015 | 9,719 | 10,411 | 9,266 | 8,137 | Upgrade
|
| Operating Income | 7,846 | 7,734 | 7,476 | 8,560 | 10,372 | 7,867 | Upgrade
|
| Interest Expense | -1,330 | -1,390 | -1,375 | -726 | -536 | -553 | Upgrade
|
| Interest & Investment Income | 1,002 | 1,078 | 879 | 272 | 43 | 65 | Upgrade
|
| Earnings From Equity Investments | -79 | -42 | -59 | -172 | -4 | -3 | Upgrade
|
| Currency Exchange Gain (Loss) | -16 | -16 | -29 | 102 | 162 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 6 | 5 | 5 | -35 | -161 | 5 | Upgrade
|
| EBT Excluding Unusual Items | 7,429 | 7,369 | 6,897 | 8,001 | 9,876 | 7,381 | Upgrade
|
| Merger & Restructuring Charges | -97 | -104 | -220 | -68 | -72 | -132 | Upgrade
|
| Gain (Loss) on Sale of Investments | 11 | 21 | -46 | -161 | 66 | 10 | Upgrade
|
| Asset Writedown | -252 | -252 | -219 | -46 | -122 | -32 | Upgrade
|
| Legal Settlements | - | - | -19 | - | - | - | Upgrade
|
| Other Unusual Items | -103 | -39 | -154 | -63 | -911 | - | Upgrade
|
| Pretax Income | 6,988 | 6,995 | 6,239 | 7,663 | 8,837 | 7,227 | Upgrade
|
| Income Tax Expense | 471 | 657 | 284 | 703 | 1,109 | 850 | Upgrade
|
| Earnings From Continuing Operations | 6,517 | 6,338 | 5,955 | 6,960 | 7,728 | 6,377 | Upgrade
|
| Net Income to Company | 6,517 | 6,338 | 5,955 | 6,960 | 7,728 | 6,377 | Upgrade
|
| Minority Interest in Earnings | -3 | -3 | 40 | -10 | -3 | -2 | Upgrade
|
| Net Income | 6,514 | 6,335 | 5,995 | 6,950 | 7,725 | 6,375 | Upgrade
|
| Net Income to Common | 6,514 | 6,335 | 5,995 | 6,950 | 7,725 | 6,375 | Upgrade
|
| Net Income Growth | 7.95% | 5.67% | -13.74% | -10.03% | 21.18% | 72.48% | Upgrade
|
| Shares Outstanding (Basic) | 381 | 382 | 386 | 392 | 394 | 396 | Upgrade
|
| Shares Outstanding (Diluted) | 382 | 383 | 388 | 394 | 397 | 399 | Upgrade
|
| Shares Change (YoY) | -1.36% | -1.29% | -1.52% | -0.76% | -0.50% | -0.99% | Upgrade
|
| EPS (Basic) | 17.10 | 16.58 | 15.53 | 17.73 | 19.61 | 16.10 | Upgrade
|
| EPS (Diluted) | 17.06 | 16.53 | 15.45 | 17.63 | 19.46 | 15.96 | Upgrade
|
| EPS Growth | 9.37% | 6.99% | -12.37% | -9.40% | 21.93% | 74.05% | Upgrade
|
| Free Cash Flow | 6,724 | 7,267 | 6,927 | 6,911 | 6,789 | 6,815 | Upgrade
|
| Free Cash Flow Per Share | 17.61 | 18.97 | 17.85 | 17.54 | 17.10 | 17.08 | Upgrade
|
| Dividend Per Share | 1.600 | 1.560 | 1.400 | 1.200 | 1.040 | 0.880 | Upgrade
|
| Dividend Growth | 11.11% | 11.43% | 16.67% | 15.38% | 18.18% | 15.79% | Upgrade
|
| Gross Margin | 41.37% | 41.39% | 40.12% | 42.24% | 50.08% | 49.67% | Upgrade
|
| Operating Margin | 18.29% | 18.04% | 17.44% | 19.06% | 26.45% | 24.42% | Upgrade
|
| Profit Margin | 15.19% | 14.77% | 13.99% | 15.47% | 19.70% | 19.79% | Upgrade
|
| Free Cash Flow Margin | 15.67% | 16.95% | 16.16% | 15.39% | 17.31% | 21.15% | Upgrade
|
| EBITDA | 10,823 | 10,842 | 10,882 | 11,941 | 12,964 | 10,192 | Upgrade
|
| EBITDA Margin | 25.23% | 25.29% | 25.39% | 26.59% | 33.06% | 31.63% | Upgrade
|
| D&A For EBITDA | 2,977 | 3,108 | 3,406 | 3,381 | 2,592 | 2,325 | Upgrade
|
| EBIT | 7,846 | 7,734 | 7,476 | 8,560 | 10,372 | 7,867 | Upgrade
|
| EBIT Margin | 18.29% | 18.04% | 17.44% | 19.06% | 26.45% | 24.42% | Upgrade
|
| Effective Tax Rate | 6.74% | 9.39% | 4.55% | 9.17% | 12.55% | 11.76% | Upgrade
|
| Revenue as Reported | 42,879 | 42,879 | 42,857 | 44,915 | 39,211 | 32,218 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.